Previous Article | Next Article 
Infection and Immunity, April 2001, p. 2535-2541, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2535-2541.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antibody Recognition of Rodent Malaria Parasite
Antigens Exposed at the Infected Erythrocyte Surface: Specificity of
Immunity Generated in Hyperimmune Mice
Maria M.
Mota,1,*
K. Neil
Brown,1
Virgilio E.
Do
Rosário,2
Anthony A.
Holder,1 and
William
Jarra1
Division of Parasitology, National Institute
for Medical Research, Mill Hill, London NW7 1AA, United
Kingdom,1 and Centro de Malaria e Outras
Doenças Tropicais, Lisbon, Portugal2
Received 25 July 2000/Returned for modification 7 September
2000/Accepted 22 December 2000
 |
ABSTRACT |
In regions where malaria is endemic, inhabitants remain susceptible
to repeated reinfection as they develop and maintain clinical immunity.
This immunity includes responses to surface-exposed antigens on
Plasmodium sp.-infected erythrocytes. Some of these parasite-encoded antigens may be diverse and phenotypically variable, and the ability to respond to this diversity and variability is an
important component of acquired immunity. Characterizing the relative
specificities of antibody responses during the acquisition of immunity
and in hyperimmune individuals is thus an important adjunct to vaccine
research. This is logistically difficult to do in the field but is
relatively easily carried out in animal models. Infections in inbred
mice with rodent malaria parasite Plasmodium chabaudi
chabaudi AS represent a good model for Plasmodium falciparum in humans. This model has been used in the present study in a comparative analysis of cross-reactive and specific immune
responses in rodent malaria. CBA/Ca mice were rendered hyperimmune to
P. chabaudi chabaudi (AS or CB lines) or Plasmodium berghei (KSP-11 line) by repeated infection with homologous
parasites. Serum from P. chabaudi chabaudi AS hyperimmune
mice reacted with antigens released from disrupted P. chabaudi
chabaudi AS-infected erythrocytes, but P. chabaudi
chabaudi CB and P. berghei KSP-11 hyperimmune serum
also contained cross-reactive antibodies to these antigens. However,
antibody activity directed against antigens exposed at the surfaces of
intact P. chabaudi chabaudi-infected erythrocytes was
mainly parasite species specific and, to a lesser extent, parasite line
specific. Importantly, this response included opsonizing antibodies,
which bound to infected erythrocytes, leading to their phagocytosis and
destruction by macrophages. The results are discussed in the context of
the role that antibodies to both variable and invariant antigens may
play in protective immunity in the face of continuous susceptibility to reinfection.
 |
INTRODUCTION |
Plasmodium sp. parasites
demonstrate inter- and intraspecies behavioral, biochemical, genetic,
and antigenic differences (17, 19). Host populations are
thus infected with a range of genetically variant parasites.
Furthermore, during an infection with Plasmodium falciparum
in a single host, a repertoire of parasite variants (32,
37), which are antigenically distinct at the
infected-erythrocyte surface, may be produced. In spite of this
diversity, it is well established that people living in areas where
malaria is endemic gradually develop naturally acquired immunity to the
disease, a fact that has encouraged research on the development of a
vaccine. However, semi-immune individuals remain susceptible to
reinfection, and it may take many infections over several years before
a level of immunity capable of preventing clinical disease is reached. Immunity involves both cell-mediated and humoral responses
(10). The latter may develop partly through the
acquisition of a repertoire of specific protective antibodies directed
against polymorphic antigens sequentially expressed by antigenically
distinct parasite variants. The finding that protective immunity can be
passively transferred to children by immunoglobulin G (IgG) antibodies
from immune adults is consistent with this suggestion (6, 26, 35). PfEMP1 (P. falciparum erythrocyte membrane
protein 1) is one such polymorphic antigen exposed on the surfaces of
infected erythrocytes. Antibody responses to this antigen in adults
remain predominantly variant specific (32) and may be
linked to protective immunity (4). However, defining the
true importance of such antigens and the specific antibody responses
directed to them in a natural infection is problematic. It is difficult
to fully characterize either the parasite population(s) infecting
individuals and populations or the immune status of those affected
(29).
Inbred naive CBA/Ca mice infected with a cloned population of
Plasmodium chabaudi chabaudi AS experience a pattern of
infection similar to that seen with P. falciparum in
nonimmune humans. Initially the parasitemia is high and acute, but then
partial resolution of the infection occurs and the infection goes
chronic. This generally low-level, chronic phase is interspersed with
recrudescences of parasitemia consisting of antigenically variant
parasites (28). For these and other reasons discussed
elsewhere (9, 17, 30, 31) this host-parasite combination
is a useful model for certain aspects of P. falciparum
infection in humans. In P. chabaudi, termination of the
initial acute phase of a primary infection (crisis) is mediated by
immunity consisting of both cell-mediated and antibody responses
(23, 39). In P. chabaudi chabaudi AS infections
the antibody-mediated part of this response is directed at parasite
line-specific epitopes predominantly exposed on the surfaces of
trophozoite- or schizont-infected erythrocytes (18, 30,
36). These antibodies enhance the phagocytosis and destruction of infected erythrocytes in vitro (30). Opsonizing
antibodies with a similar specificity have been associated with
protection in P. falciparum infections (11,
12). Full resolution of a primary P. chabaudi
chabaudi AS infection renders mice relatively resistant to
reinfection with the same parasite line, but they remain susceptible to
reinfection with heterologous parasites (17). After six or
seven further injections with large numbers of P. chabaudi
chabaudi AS-parasitized erythrocytes, the resulting hyperimmune
mice are refractory to further challenge with homologous parasites but
remain susceptible to heterologous challenge (19; W. Jarra
and K. N. Brown, unpublished results). This situation is similar
to that seen in protective (hyper-) immunity in humans.
In order to further investigate the specificity of immune responses
operating in such situations, we examined the specificity of antibody
binding to P. chabaudi chabaudi AS-infected erythrocytes in
the sera of mice hyperimmune to either the AS or CB lines of P. chabaudi chabaudi or Plasmodium berghei KSP-11. The
highest levels of antibody binding were seen with P. chabaudi
chabaudi AS hyperimmune serum although cross-reactive antibodies
were evident in the other sera. Antibody binding to the surface of
intact P. chabaudi chabaudi AS-infected erythrocyte was
predominantly parasite line specific. Furthermore, a direct correlation
between the amount of antibody binding to infected erythrocytes and the
phagocytosis and destruction of these cells by macrophages in vitro was established.
 |
MATERIALS AND METHODS |
Parasites and mice.
CBA/Ca mice, P. chabaudi
chabaudi (AS and CB lines), and P. berghei (KSP-11
line) parasites were maintained and prepared as previously described
(17). The parasites were originally supplied as cloned
lines by D. Walliker (WHO Registry of Standard Malaria Parasites,
Institute of Cell, Animal and Population Biology, University of
Edinburgh, Edinburgh, United Kingdom). The erythrocytic stage of
P. chabaudi chabaudi has a 24-h synchronous cycle of
development. Thus, to obtain infected erythrocytes containing mature
parasites, blood containing mainly trophozoites was harvested and the
parasites were allowed to develop further by incubation for 2 h in
culture medium (RPMI 1640, 25 mM HEPES, 25 µg of gentamicin
ml
1, 2 mM glutamine, 2 mM CaCl2, 10% fetal
calf serum [FCS]) at 37°C. Noninfected blood was always treated
similarly as a control.
Preparation of HIS.
Primary infections were initiated in
groups of mice by intraperitoneal injection of 5 × 104 infected erythrocytes of either the AS or CB lines of
P. chabaudi chabaudi or the KSP-11 line of P. berghei. Parasitemia was assessed by microscopy on Giemsa-stained
blood smears. When parasitemia was undetectable or barely detectable
(with P. berghei KSP-11) after full resolution of this
primary infection, which usually occurred about 2 to 3 months after the
initial inoculation, surviving mice were injected six to eight times
intraperitoneally, at approximately monthly intervals, with between
4 × 107 and 2 × 108 homologous
infected erythrocytes. Hyperimmune serum (HIS) was harvested 10 to 12 days after the final infection. Normal serum (NS) was obtained from
age- and weight-matched uninfected adult CBA/Ca mice.
Surface immunofluorescence antibody assay.
Antibody binding
to the surfaces of infected erythrocytes was assayed as previously
described (30). Infected erythrocytes and noninfected
erythrocytes were obtained from CBA/Ca infected and noninfected mice,
respectively, and washed three times in Krebs's buffered saline
containing 0.2% glucose (KGS) (17) and 1% bovine serum
albumin (KGS-BSA) by centrifugation at 1,000 × g.
After 2 h in culture medium, these cells were incubated for 30 to
60 min at 37°C with plasma or serum samples diluted 1:4 to 1:10 in
KGS-BSA for the individual experiments described in Results. These
cells were then washed twice by resuspension in ice-cold KGS-BSA as
described above. A solution containing fluorescein isothiocyanate-conjugated anti-mouse IgG antibody (Sigma) diluted in
KGS-BSA was used to resuspend the cell pellet, and the mixture was
incubated for a further 15 to 30 min at 37°C. The cells were washed
twice more as described above. In some experiments, parasite DNA in
infected cells was stained with ethidium bromide to allow distinction
between infected and uninfected cells. In these cases the washed cell
pellet was incubated for 3 to 5 min with 50 µl of buffer containing
ethidium bromide (1 µg · ml
1) and the cells were
then washed twice as described above before resuspension in 1 ml of
KGS-BSA. Samples were analyzed in a Becton-Dickinson FACStar Plus
fluorescence-activated cell sorter (FACS).
ELISA.
Enzyme-linked immunosorbent assays (ELISAs) were
performed as previously described (30). To obtain the
parasite antigen, P. chabaudi chabaudi AS trophozoite stage
parasites were harvested from CBA/Ca mice at 40% parasitemia. The
blood was passed through a column containing CF11 cellulose powder
(Whatman, Maidstone, United Kingdom) to remove leukocytes, and, after
two washes in KGS by centrifugation, the cell pellet was resuspended in
KGS containing 0.05% saponin to lyse erythrocyte membranes. After centrifugation (at 18,000 × g) the pellet was
solubilized with 100 mM Tris-HCl, pH 8.0, containing 1% (wt/vol)
Triton X-100 and 5 mM EDTA, and after a second centrifugation (at
200,000 × g) for 5 min at 4°C, the supernatant was
retained. Each well of a 96-well microtiter plate was coated with an
appropriate amount of the detergent-soluble antigen diluted in coating
buffer (100 mM Tris-HCl, pH 8.0). After overnight incubation at 4°C
the plates were washed with Tris-HCl-buffered saline containing 0.05%
(vol/vol) Tween 20 and any uncoated sites were blocked with BLOTTO
(Tris-HCl-buffered saline containing 0.05% Tween 20 and 5% [wt/vol]
dried milk). Serial dilutions in BLOTTO of either NS or serum from mice
hyperimmune to P. chabaudi chabaudi AS (AS-HIS), P. chabaudi chabaudi CB (CB-HIS), or P. berghei KSP-11
(PBK-HIS) were then added. After incubation at room temperature for
2 h the plates were washed as described above. An anti-mouse Ig
affinity-purified biotin-conjugated antibody (The Binding Site Co.,
Birmingham, United Kingdom) was added, and the plates were incubated at
room temperature for 45 min. In some experiments this step was
performed with biotin-conjugated antibodies specific for either mouse
IgG1 or IgG2a. After six washes, exposure to
streptavidin-conjugated alkaline phosphatase (Sigma) was performed,
followed by six more washes and incubation with substrate buffer (10 mM
diethanolamine [pH 9.5], 0.5 mM MgCl2) for 30 min. After
exposure to the substrate p-nitrophenyl phosphate (Sigma),
color development was measured using a Titertek Multiskan MCC 340 reader with a 405-nm filter. All samples were tested in triplicate.
Background values for antibody binding were obtained from plates coated
only with buffer (without antigen). These values were subtracted from
the values obtained for binding to extracts from infected or uninfected erythrocytes.
Phagocytosis assay.
Macrophages were obtained from CBA/Ca
mice by peritoneal lavage with 3 ml of ice-cold RPMI 1640 medium
containing 5 U of heparin ml
1. An erythrocyte-free
leukocyte preparation of 1 × 106 to 2 × 106 cells ml
1 was usually obtained, and 1-ml
aliquots were added to Leighton tissue culture tubes (Wheaton)
containing coverslips. The tubes were gassed with 7%
CO2-5% O2-88% N2 and incubated
for 1 to 2 h at 37°C. Cells nonadherent to the coverslips were
removed by careful washing of the coverslips in situ with 1 ml of RPMI
1640 medium.
RPMI 1640 (1 ml) containing 10% (vol/vol) FCS was added to the tubes,
which were then regassed and incubated at 37°C for 2 h. During
this period washed infected erythrocytes from P. chabaudi chabaudi AS-infected mice and erythrocytes from uninfected mice were prepared in RPMI 1640-10% FCS. These cells were incubated at
37°C for 1 h with the different HIS samples, or with
phosphate-buffered saline (PBS) as a control, in a G24 environmental
incubator (Edison) and shaken at 70 to 80 rpm. The cells were then
pelleted by centrifugation, washed three times with RPMI 1640-10%
FCS, and resuspended in the same medium, and 1 ml of cell suspension
(~108 cells) was added to each Leighton tube as
appropriate. After a further incubation of 1 h at 37°C,
nonadherent and noningested erythrocytes were removed from the
macrophage-coated coverslips by gentle aspiration and by washing the
coverslips three times with PBS. Noningested but adherent erythrocytes
were then lysed by a brief (20-s) treatment with cold water, followed
by an additional wash with PBS. The number of macrophages containing
phagocytosed infected erythrocytes and the number containing uninfected
erythrocytes were then determined semiquantitatively by microscopy and
quantitatively by luminometry. Adherent cells on the coverslips were
fixed with methanol and stained with Giemsa's reagent prior to
examination by microscopy. The results are presented as the phagocytic
index, i.e., the percentage of macrophages containing infected or
uninfected erythrocytes, and the number of internalized cells that the
macrophages contained (1, 2 or 3, 4 to 6, or >6). To fully quantify
phagocytosis, adherent macrophages were solubilized in 400 µl of 0.5 M NaOH containing 0.025% (vol/vol) Triton X-100. Ingested erythrocyte hemoglobin and parasite-derived hemozoin were then measured by a
luminescence method (38). The protoheme of the ingested
hemoglobin catalyzes the production of chemiluminescence by luminol
(5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma Chemical Co.) and
tert-butylhydroperoxide (Sigma Chemical Co.) at alkaline pH
according to the reaction luminol + 2 tert-butylhydroperoxide
aminophthalic acid + N2 + 2 butanol + light. The amount of emitted light is proportional to the heme concentration and thus to the numbers
of ingested cells.
In these experiments, chemiluminescence was elicited by injecting 100 µl of a tert-butylhydroperoxide-EDTA solution (containing 3.7 mM tert-butylhydroperoxide and 3 mM EDTA dissolved in
0.1 M NaOH) into a test tube containing 5 µl of solubilized
macrophages in 100 µl of alkaline luminol-EDTA solution (containing 1 mg of luminol ml
1 and 3 mM EDTA dissolved in 0.1 M NaOH).
Injection of tert-butylhydroperoxide triggered photon
emission and counting. Since light emission reached its maximum after
less than 1 s and did not decrease until 2.5 s, the
integrated photon counting time was set at 2 s. Chemiluminescence was measured on a Clinilumat luminometer (Berthold Instruments; LB9502). Reagent luminescence and eigen luminescence due to macrophage heme-containing proteins were predetermined using the appropriate controls and subtracted from the results obtained with the experimental samples.
Statistical analysis.
Data were analyzed using Student's
t test to compare paired results, with P values
of <0.05 considered to be significant.
 |
RESULTS |
IgG in hyperimmune serum raised by P. chabaudi AS
infection binds to surface antigens of intact P. chabaudi
chabaudi AS-infected erythrocytes.
Infected erythrocytes
were harvested from heavily infected mice at 2 to 3 days postinfection
and processed as described in Materials and Methods to yield parasites
that were predominantly mature trophozoites and schizonts. Erythrocytes
from infected or noninfected mice were incubated with NS or AS-HIS, and
antibody binding was detected using fluorescein
isothiocyanate-conjugated anti-mouse IgG and FACS analysis. Anti-mouse
IgG was used since the IgG fraction of AS-HIS obtained by fractionation
on protein G was the only fraction showing significant binding to the
surfaces of parasitized erythrocytes (data not shown). Thirty-three
percent of cells from the infected population and incubated with AS-HIS had surface-bound IgG, while only 1.9% of cells bound IgG from NS
(Fig. 1A), and this difference was
statistically significant (P < 0.01). Only low levels
of IgG binding were detectable in noninfected erythrocytes incubated
with NS or AS-HIS (Fig. 1A). In some experiments infected erythrocytes
were prelabeled with IgG from AS-HIS and counterstained with ethidium
bromide and the double-stained cells were then examined by FACS. In
these experiments it was observed that (i) significantly higher
(P < 0.01) numbers of infected cells than uninfected
cells bound IgG and (ii) the numbers of uninfected erythrocytes within
the population of cells from infected mice that bound IgG were
significantly higher than (P < 0.01) the number of
IgG-labeled erythrocytes in the cell population from uninfected mice
(Fig. 1B).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
immunofluorescence analysis of AS-HIS: IgG antibody
binding to the surfaces of intact P. chabaudi chabaudi
AS-infected erythrocytes. (A) Erythrocytes from a noninfected mouse (E)
and parasitized erythrocytes (PE) containing mature parasites were
incubated with NS or AS-HIS, and the numbers of cells with IgG bound to
the surface were quantified in triplicate samples by FACS analysis. (B)
Infected (IE) and uninfected (NIE) erythrocytes in mice infected with
P. chabaudi chabaudi AS were differentiated by staining
parasite DNA with ethidium bromide. Erythrocytes from uninfected mice
(E) and the infected-erythrocyte population (PE) were incubated with
either NS or AS-HIS. Each bar represents the percentage of cells within
a window of positive fluorescence; the window for no or background
fluorescence was predetermined by incubating identical samples with KGS
without the primary antibody, followed by the secondary antibody. All
data are the means of three independent experiments ± standard
deviations.
|
|
Comparison of the relative binding efficiencies to P. chabaudi chabaudi AS surface antigens of IgG from homologous and
heterologous HIS.
Infected erythrocytes from P. chabaudi
chabaudi AS-infected mice were preincubated with AS-HIS, CB-HIS,
PBK-HIS, or NS, and the percentage of cells that bound IgG on their
surfaces was determined. As shown in Fig.
2, significantly higher numbers of cells
bound IgG from AS-HIS (35%) than from either PBK-HIS (7%;
P < 0.01) or CB-HIS (20%; P < 0.05).
Preincubation of P. chabaudi chabaudi AS-infected
erythrocytes with NS produced a background level of antibody binding
similar to that produced by PBK-HIS but significantly less
(P < 0.01) than that produced with CB-HIS (Fig. 2).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Immunofluorescence analysis of AS-HIS, CB-HIS, and
PBK-HIS: relative binding efficiencies of IgG to surface antigens of
intact P. chabaudi chabaudi AS. Erythrocytes containing
mature parasites were incubated with NS, AS-HIS, CB-HIS, or PBK-HIS,
and antibody binding to the cell surface was quantified in duplicate
samples by FACS analysis. Infected (IE) and uninfected (NIE)
erythrocytes were differentiated by staining parasite DNA with ethidium
bromide. Each bar represents the proportion of cells within a window of
positive fluorescence predetermined by incubating parasitized
erythrocytes with KGS alone followed by the secondary antibody. All
data are means of three independent experiments ± standard
deviations.
|
|
Binding of IgG to P. chabaudi chabaudi AS-infected
erythrocytes: the relative binding efficiencies of antibodies from
homologous and heterologous HIS.
The differences in antibody
binding observed in the surface immunofluorescence assay could be due
to differences in the levels of IgG isotype in the different sera under
analysis. To exclude this possibility, the capacities of these sera to
react with common antigens in a detergent extract of infected
erythrocytes were analyzed by ELISA. None of the hyperimmune sera
contained antibodies that reacted with the lysate of uninfected
erythrocytes, and the reactivity of NS with the parasitized erythrocyte
lysate was equally low (Fig. 3). In
contrast, all three hyperimmune sera reacted strongly with antigens in
the infected-erythrocyte lysate and at a level significantly above the
reactivity shown by NS (P < 0.01 in all cases). There
was no apparent difference in the relative levels of IgG1
and IgG2a from the different HIS samples that bound to the
parasite antigen (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
ELISA analysis of IgG binding to antigens released into
P. chabaudi chabaudi AS lysates. Shown is a comparison of
AS-HIS, CB-HIS, and PBK-HIS. HIS and NS were tested against detergent
extracts of erythrocytes from either noninfected mice (E) or P. chabaudi chabaudi AS-infected mice (PE). Total antibody binding
was determined by measuring the mean absorbance obtained with the
chromagenic substrate. All data are means of three independent
experiments ± standard deviations.
|
|
Phagocytosis of P. chabaudi chabaudi AS-infected
erythrocytes by macrophages: the relative opsonizing activities of IgG
from homologous and heterologous HIS.
The antibody binding assays
described above do not identify a potential functional role for
antibody binding to antigens exposed at the infected-erythrocyte
surface. However, opsonizing antibody activity can enhance the uptake
and destruction of infected erythrocytes by macrophages in vitro and
might be a correlate of protective antibody activity in vivo. More than
80% of the macrophages exposed to infected erythrocytes preincubated
with AS-HIS had phagocytosed infected erythrocytes, and, of these,
approximately 40% contained four or more infected erythrocytes (Fig.
4A). Although a similar level of
phagocytosis was observed with P. chabaudi chabaudi
AS-infected erythrocytes preincubated with CB-HIS (70%), much lower
levels were observed for PBK-HIS-, NS-, or KGS (control)-treated target cells (40, 35, and 20%, respectively) (Fig. 4A). In each case when
infected erythrocytes were preincubated with heterologous HIS,
individual macrophages contained, on average, fewer internalized infected cells than AS-HIS-preincubated cells (Fig. 4A). There was no
significant difference in the percentage of phagocytic macrophages
between cells preincubated with AS-HIS and those preincubated with
CB-HIS. However, this difference became significant when AS-HIS was
compared with either PbK-HIS, NS, or KGS (P > 0.01).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Phagocytosis of P. chabaudi chabaudi
AS-infected erythrocytes by macrophages. Shown are the relative
opsonizing efficiencies of IgG from homologous or heterologous HIS.
P. chabaudi chabaudi AS-infected erythrocytes containing
mature parasites were incubated with AS-HIS, CB-HIS, PBK-HIS, NS, or
KGS and then exposed to macrophages in vitro. (A) Percentages of
macrophages with internalized infected erythrocytes (phagocytic
indices) and numbers of cells internalized by individual macrophages
(left, NS; right, AS-HIS); (B) chemiluminescence values produced by the
presence of ingested-erythrocyte hemoglobin or parasite-derived heme as
detected by a luminescence method.
|
|
In some experiments, the extent of phagocytosis was quantified by
determining the level of intracellular hemoglobin by a
chemiluminescence method where the level of hemoglobin correlated with
the numbers of internalized erythrocytes. Thus, preincubation of
infected erythrocytes with AS-HIS resulted in a significantly enhanced chemiluminescence signal compared to that resulting from incubation with either NS (P > 0.01), CB-HIS (P > 0.05), PBK-HIS (P > 0.01), or the PBS control
(Fig. 4B). There was no significant difference between the
internalization of infected cells preincubated with PBK-HIS and that of
infected cells preincubated with NS (Fig. 4B).
 |
DISCUSSION |
It is important to recognize and investigate the role played by
diversification and expansion of malaria parasite antigen pools in the
efficacy and specificity of the immunity induced and in immune evasion.
Both specific and cross-reactive immune responses have been identified
in a wide range of malaria infections including those of humans
(17, 20, 30, 33). However, in many cases infections are
not clonal, and the phenotype of the infecting parasites, the history
of infections experienced, and the true immune status of the host
cannot be determined readily (29). Using P. chabaudi
chabaudi- infected erythrocytes as the target, we have analyzed
the binding and specificity of antibodies generated in mice repeatedly
infected with homologous blood stage parasites of the AS and CB lines
of P. chabaudi chabaudi and with P. berghei
KSP-11. As demonstrated by ELISA analysis, such an immunization regimen
results in the induction of strong cross-reactive antibody responses to
internal antigens of P. chabaudi chabaudi AS-infected
erythrocytes. This finding is in agreement with previous results, as
cross-reactive antibodies are also found in acute-phase plasma taken
from P. chabaudi chabaudi AS-infected mice undergoing crisis
and in the serum from animals which had recovered from a single or
multiple reinfection episodes (19, 30). In contrast, antibody responses in HIS to antigens on the surface of the infected erythrocyte are largely parasite species and, to a lesser extent, parasite line specific, as demonstrated here by surface
immunofluorescence and the phagocytosis assay. The cross-reactivity of
antibodies induced in CB hyperimmune mice correlated with the higher
level of phagocytosis observed in vitro when cells preincubated with CB-HIS were compared to those preincubated with PBK-HIS or NS. Such
cross-reactivity between the AS and CB parasite lines was not observed
for antibodies in serum harvested during crisis (30). This
difference might reflect the appearance, due to longer or greater
exposure to parasite antigens, of a response capable of recognizing
invariant or shared epitopes, thus transcending parasite variant and
line antigenic differences.
Antibody binding to the surfaces of noninfected erythrocytes in
infected blood was significantly higher than binding to noninfected erythrocytes from normal mice. This difference could be explained by
the adherence of parasite-derived antigens (during schizont rupture)
to, or their interaction with, the surfaces of neighboring noninfected
erythrocytes. It is also known that erythrocytes infected with
Plasmodium show not only changes in their membranes due to the presence of parasite proteins but also modification of naturally occurring host cell proteins, such as band 3 (1, 40).
Whether band-3 modification occurs only in infected erythrocytes or
also in some noninfected erythrocytes during malaria infections is not
known. The fact that noninfected erythrocytes can be recognized by an antibody of a malaria infection might reflect the in vivo clearance of both infected and noninfected erythrocytes, increasing the
risk of anemia in malaria infections. However, in the present study,
when infected blood was incubated with HIS and exposed to macrophages,
little or no phagocytosis of noninfected erythrocytes was observed
(results not shown).
The immune mechanisms by which malaria parasites are neutralized or
eliminated and the identity of the protective antigens involved have
been extensively studied (10, 15, 22). The relative
contributions of these antigens to the triggering of cell- and
antibody-mediated protective immune responses and the relative
specificities of these responses have yet to be fully determined.
Antibodies in HIS bind to antigens exposed at the surfaces of P. chabaudi chabaudi AS-infected erythrocytes as well as to antigens
only exposed in disrupted target cells. Surface-exposed antigens in
P. falciparum might include PfEMP-1, Pf332, PfAARP1 (asparagine- and aspartate-rich protein 1), and rifins (3, 5, 8,
14, 21, 24). Several of these antigens are coded for by
multigene families, giving them the potential for extensive diversity
and variability. At present it is not known if homologues of these
antigens for P. chabaudi chabaudi exist. Antigens of the
merozoite apical complex (e.g., AMA-1, RAP1, and RAP2) or proteins
exposed on the merozoite surface in developing schizonts (e.g., MSP-1)
also induce strong antibody responses in a number of malaria
infections. In the present study it is possible that one or several of
these (internal) antigens are recognized by the antibody in the ELISA.
Certainly homologues of MSP-1 and AMA-1 in P. chabaudi
chabaudi have been characterized (25, 27). However,
these antigens are not encoded by multigene families and are not
considered to be clonally variable, and the immune responses they
induce are often specific for the immunizing parasite line (7,
16, 34).
For P. falciparum, it has been suggested that
variant-specific antibodies against antigens (such as PfEMP-1) exposed
at the infected-erythrocyte surface are important in the acquisition of
immunity in children and in maintaining immunity throughout life
(4). Others have proposed that (in adults) antibodies to
nonvariable antigens are involved in strain-transcending immunity (2, 13). Antibodies against invariant epitopes on
surface-exposed antigens of infected erythrocytes have been identified
in adult serum (24). However, the antibody response to
phenotypically variable parasite surface antigens (as measured by
agglutination of infected cells) remains predominantly variant specific
(32). This situation in humans infected with P. falciparum is similar to that shown here for P. chabaudi
chabaudi AS infections in mice.
P. chabaudi chabaudi AS also undergoes antigenic variation,
and antibody responses to variant-specific epitopes of antigens exposed
at the surfaces of infected erythrocytes may also be important in
protection (28, 30). The identification and
characterization of the genes that code for these potentially important
proteins in P. chabaudi chabaudi are being actively pursued.
 |
ACKNOWLEDGMENTS |
We thank Chris Atkins for help with the FACS analysis and Keiran
O'Dea for valuable discussions.
Maria M. Mota was supported by "Programa Ciência"
(BM2612/92), JNICT, Portugal.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: New York
University Medical Center, Division of Immunology (MSB 131), 550 First
Ave., New York, N.Y. 10016. Phone: (212) 263-5346. Fax: (212) 263-8179. E-mail: motam01{at}med.nyu.edu.
Editor:
J. M. Mansfield
 |
REFERENCES |
| 1.
|
Aikawa, M.,
I. J. Udeinya,
J. Rabbege,
M. Dayan,
J. H. Leech,
R. J. Howard, and L. H. Miller.
1995.
Structural alteration of the membrane of erythrocytes infected with Plasmodium falciparum.
J. Protozool.
32:424-429.
|
| 2.
|
Anita, R.,
M. A. Nowak, and R. M. Anderson.
1996.
Antigenic variation and the within-host dynamics of parasites.
Proc. Natl. Acad. Sci. USA
93:985-989[Abstract/Free Full Text].
|
| 3.
|
Barale, J. C.,
D. Candelle,
G. Attal-Bonnefoy,
P. Dehoux,
S. Bonnefoy,
L. Pereira da Silva, and G. Lansley.
1997.
Plasmodium falciparum AARP1, a giant protein containing repeated motifs rich in asparagin and aspartate residues, is associated with the infected erythrocyte membrane.
Infect. Immun.
65:3003-3010[Abstract].
|
| 4.
|
Bull, P. C.,
B. S. Lowe,
M. Kortok,
C. S. Molyneux,
C. I. Newbold, and K. Marsh.
1998.
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.
Nat. Med.
4:358-360[CrossRef][Medline].
|
| 5.
|
Cheng, Q.,
N. Cloonan,
K. Fisher,
J. Thompson,
G. Waine,
M. Lanzer, and A. Saul.
1998.
Stevor and rif are Plasmodium falciparum multicopy gene families which potentially encode variant antigens.
Mol. Biochem. Parasitol.
97:161-176[CrossRef][Medline].
|
| 6.
|
Cohen, S.,
I. A. McGregor, and S. P. Carrington.
1961.
Gammaglobulin and acquired immunity to human malaria.
Nature
192:733-737[CrossRef][Medline].
|
| 7.
|
Crewther, P. E.,
M. L. Matthew,
R. H. Flegg, and R. F. Anders.
1996.
Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes.
Infect. Immun.
64:3310-3317[Abstract].
|
| 8.
|
Fernandez, V.,
M. Hommel,
Q. Chen,
P. Hagblom, and M. Wahlgren.
1999.
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses.
J. Exp. Med.
190:1393-1404[Abstract/Free Full Text].
|
| 9.
|
Gilks, C. F.,
D. Walliker, and C. I. Newbold.
1990.
Relationships between sequestration, antigenic variation and chronic parasitism in Plasmodium chabaudi chabaudi a rodent malaria model.
Parasite Immunol.
12:45-64[Medline].
|
| 10.
|
Good, M. F., and D. L. Doolan.
1999.
Immune effector mechanisms in malaria.
Curr. Opin. Immunol.
11:412-419[CrossRef][Medline].
|
| 11.
|
Groux, H., and J. Gysin.
1990.
Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses.
Res. Immunol.
141:529-542[CrossRef][Medline]
|
| 12.
|
Groux, H.,
R. Perraut,
O. Garraud,
J. P. Poingt, and J. Gysin.
1990.
Functional characterization of the antibody-mediated protection against blood stages of Plasmodium falciparum in the monkey Saimiri sciureus.
Eur. J. Immunol.
20:2317-2323[Medline].
|
| 13.
|
Gupta, S.,
R. W. Snow,
C. A. Donnelly,
K. Marsh, and C. I. Newbold.
1999.
Immunity to non-cerebral severe malaria is acquired after one or two infections.
Nat. Med.
5:340-343[CrossRef][Medline].
|
| 14.
| Hinterberg, K., A. Scherf, J. Gysin, T. Toyoshima, M. Aikawa, J. C. Mazie, L. P. da Silva, and D. Mattei.
Plasmodium falciparum: the Pf332 antigen is secreted from
the parasite by a brefeldin A-dependent pathway and is translocated to
the erythrocyte membrane via the Maurer's clefts. Exp. Parasitol.
79:279-291.
|
| 15.
|
Holder, A. A.
1999.
Malaria vaccines.
Proc. Natl. Acad. Sci. USA
96:1167-1169[Free Full Text].
|
| 16.
|
Holder, A. A., and R. R. Freeman.
1984.
Protective antigens of rodent and human bloodstage malaria.
Philos. Trans. R. Soc. Lond. B.
307:171-177[Medline].
|
| 17.
|
Jarra, W., and K. N. Brown.
1985.
Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection.
Parasite Immunol.
7:595-606[Medline].
|
| 18.
|
Jarra, W., and K. N. Brown.
1989.
Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
Parasite Immunol.
11:1-13[Medline].
|
| 19.
|
Jarra, W.,
L. A. Hills,
J. C. March, and K. N. Brown.
1986.
Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum.
Parasite Immunol.
8:239-254[Medline].
|
| 20.
|
Jeffery, G. M.
1966.
Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium.
Bull. W. H. O.
35:873-882[Medline].
|
| 21.
|
Kyes, S. A.,
J. A. Rowe,
N. Kriek, and C. I. Newbold.
1999.
Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum.
Proc. Natl. Acad. Sci. USA
96:9333-9338[Abstract/Free Full Text].
|
| 22.
|
Langhorne, J.
1994.
The immune response to the blood stages of Plasmodium in animal models.
Immunol. Lett.
41:99-102[CrossRef][Medline].
|
| 23.
|
Langhorne, J.,
C. Cross,
E. Seixas,
C. Li, and T. von der Weid.
1998.
A role for B cells in the development of T cell helper finction in a malaria infection in mice.
Proc. Natl. Acad. Sci. USA
95:1730-1734[Abstract/Free Full Text].
|
| 24.
|
Marsh, K., and R. J. Howard.
1986.
Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants.
Science
231:150-153[Abstract/Free Full Text].
|
| 25.
|
Marshall, V. M.,
M. G. Peterson,
A. M. Lew, and D. J. Kemp.
1989.
Structure of the apical membrane antigen I (AMA-1) of Plasmodium chabaudi.
Mol. Biochem. Parasitol.
37:281-283[CrossRef][Medline].
|
| 26.
|
McGregor, I. A.,
S. P. Carrington, and S. Cohen.
1963.
Treatment of East African P. falciparum with West African human gammaglobulin.
Trans. R. Soc. Trop. Med. Hyg.
57:170-175[CrossRef].
|
| 27.
|
McKean, P. G.,
K. O'Dea, and K. N. Brown.
1993.
Nucleotide sequence analysis and epitope mapping of the merozoite surface protein 1 from Plasmodium chabaudi chabaudi AS.
Mol. Biochem. Parasitol.
62:199-209[CrossRef][Medline].
|
| 28.
|
McLean, S. A.,
C. D. Pearson, and R. S. Phillips.
1982.
Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice.
Exp. Parasitol.
54:296-302[CrossRef][Medline].
|
| 29.
|
Miller, L. H.,
M. F. Good, and D. C. Kaslow.
1997.
The need for assays predictive of protection in development of malaria bloodstage vaccines.
Parasitol. Today
13:46-47.
|
| 30.
|
Mota, M. M.,
K. N. Brown,
A. A. Holder, and W. Jarra.
1998.
Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surface of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro.
Infect. Immun.
66:4080-4086[Abstract/Free Full Text].
|
| 31.
|
Mota, M. M.,
W. Jarra,
L. Hirst,
P. Patnaik, and A. A. Holder.
2000.
Plasmodium chabaudi infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ specific way.
Infect. Immun.
68:4135-4144[Abstract/Free Full Text].
|
| 32.
|
Newbold, C. I.,
R. Pinches,
D. J. Roberts, and K. Marsh.
1992.
Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific.
Exp. Parasitol.
75:281-292[CrossRef][Medline].
|
| 33.
|
Pazzaglia, G., and W. E. Woodward.
1982.
An analysis of the relationship of host factors to clinical falciparum malaria by multiple regression techniques.
Am. J. Trop. Med. Hyg.
31:202-210.
|
| 34.
|
Renia, L.,
I. T. Ling,
M. Marussig,
F. Miltgen,
A. A. Holder, and D. Mazier.
1997.
Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
Infect. Immun.
65:4419-4423[Abstract].
|
| 35.
|
Sabchareon, A.,
T. Burnouf,
D. Ouattara,
P. Attanath,
H. Bouharoun-Taypun,
P. Chantavanich,
C. Foucault,
T. Chongsuphajaisiddhi, and P. Druilhe.
1991.
Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria.
Am. J. Trop. Med. Hyg.
45:297-308.
|
| 36.
|
Snounou, G.,
W. Jarra,
S. Viriyakosol,
J. C. Wood, and K. N. Brown.
1989.
Use of a DNA probe to analyse the dynamics of infection with rodent malaria parasites confirms that parasite clearance during crisis is predominantly strain- and species-specific.
Mol. Biochem. Parasitol.
37:37-46[CrossRef][Medline].
|
| 37.
|
Staalsoe, T., and L. Hviid.
1998.
The role of variant specific immunity in asymptomatic malaria infections: maintaining a fine balance.
Parasitol. Today
14:177-178.
|
| 38.
|
Turrini, F.,
H. Ginsburg,
F. Bussolino,
G. P. Pescarmona,
M. V. Serra, and P. Arese.
1992.
Phagocytosis of Plasmodium falciparum infected human red blood cells by human monocytes: involvement of immune and non-immune determinants and dependence of parasite development stage.
Blood
80:801[Abstract/Free Full Text].
|
| 39.
|
Weidanz, W. P.,
J. R. Kemp,
J. M. Batchelder,
F. K. Cigel,
M. Sandor, and H. C. Heyde.
1999.
Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria.
J. Immunol.
162:7383-7388[Abstract/Free Full Text].
|
| 40.
|
Winograd, E.,
J. R. Greenan, and I. W. Sherman.
1987.
Expression of senescent antigen on erythrocytes infected with knobby variant of the human malaria parasite Plasmodium falciparum.
Proc. Natl. Acad. Sci. USA
84:1931-1935[Abstract/Free Full Text].
|
Infection and Immunity, April 2001, p. 2535-2541, Vol. 69, No. 4
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2535-2541.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rainczuk, A., Scorza, T., Spithill, T. W., Smooker, P. M.
(2004). A Bicistronic DNA Vaccine Containing Apical Membrane Antigen 1 and Merozoite Surface Protein 4/5 Can Prime Humoral and Cellular Immune Responses and Partially Protect Mice against Virulent Plasmodium chabaudi adami DS Malaria. Infect. Immun.
72: 5565-5573
[Abstract]
[Full Text]
-
Rainczuk, A., Scorza, T., Smooker, P. M., Spithill, T. W.
(2003). Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted and Secretory DNA Vectors. Infect. Immun.
71: 4506-4515
[Abstract]
[Full Text]